Advertisement

Russian Chemical Bulletin

, Volume 67, Issue 11, pp 2148–2151 | Cite as

The effect of laminins on chemoresistance of colorectal cancer cells

  • D. V. MaltsevaEmail author
  • G. S. Zakharova
  • S. A. Rodin
  • A. G. Tonevitsky
Brief Communications

Abstract

Earlier, the data on the ability of laminin-332 to protect liver cancer cells from apoptosis caused by doxorubicin, sorafenib, and gefitinib have been obtained. In order to answer the question whether this action of laminins is common for cancer cells of other types, we estimated the effect of several laminin isoforms on the survival of two colorectal cancer cell lines (RKO and SW-480) when treated with chemotherapeutic agents used in the colon cancer therapy (5-fluorouracil, regorafenib, and sorafenib). The data obtained suggest that this action of laminins is not universal and is likely governed by individual features of cancer cells.

Key words

laminin-332 (laminin-5) laminin-511 (laminin-10) laminin-521 (laminin-11) colorectal cancer RKO SW-480 5-fluorouracil regorafenib sorafenib drug resistance 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. W. Johnstone, A. A. Ruefli, S. W. Lowe, Cell, 2002, 108, 153.CrossRefGoogle Scholar
  2. 2.
    M. G. Rakhimov, A. Y. Maruk, A. B. Bruskin, Russ. Chem. Bull., 2016, 65, 363.CrossRefGoogle Scholar
  3. 3.
    U. Marx, T. B. Andersson, A. Bahinski, M. Beilmann, S. Beken, F. R. Cassee, M. Cirit, M. Daneshian, S. Fitzpatrick, O. Frey, C. Gaertner, C. Giese, L. Griffith, T. Hartung, M. B. Heringa, J. Hoeng, W. H. de Jong, H. Kojima, J. Kuehnl, M. Leist, A. Luch, I. Maschmeyer, D. Sakharov, A. Sips, T. Steger-Hartmann, D. Tagle, A. Tonevitsky, T. Tralau, S. Tsyb, A. van de Stolpe, R. Vandebriel, P. Vulto, J. Wang, J. Wiest, M. Rodenburg, A. Roth, ALTEX, 2016, 33, 272.Google Scholar
  4. 4.
    G. Langley, C. P. Austin, A. K. Balapure, L. S. Birnbaum, J. R. Bucher, J. Fentem, S. C. Fitzpatrick, J. R. Fowle, R. J. Kavlock, H. Kitano, B. A. Lidbury, A. R. Muotri, S.-Q. Peng, D. Sakharov, T. Seidle, T. Trez, A. Tonevitsky, A. van de Stolpe, M. Whelan, C. Willett, Environ. Health Perspect., 2015, 123.Google Scholar
  5. 5.
    S. V. Nikulin, M. P. Raigorodskaya, A. A. Poloznikov, G. S. Zakharova, U. Schumacher, D. Wicklein, C. Stürken, K. Riecken, K. A. Fomicheva, B. Y. Alekseev, M. Y. Shkurnikov, Bull. Exp. Biol. Med., 2018, 164, 688.CrossRefGoogle Scholar
  6. 6.
    S. V. Nikulin, E. A. Tonevitsky, A. A. Poloznikov, Russ. Chem. Bull., 2017, 66, 150.CrossRefGoogle Scholar
  7. 7.
    A. A. Zakhariants, O. A. Burmistrova, A. A. Poloznikov, D. A. Sakharov, M. Y. Shkurnikov, Bull. Exp. Biol. Med., 2016, 162, 170.CrossRefGoogle Scholar
  8. 8.
    S. A. Rodin, D. V. Maltseva, Res. Pract. Med. J., 2017, 4, 73.CrossRefGoogle Scholar
  9. 9.
    A. Domogatskaya, S. Rodin, K. Tryggvason, Annu. Rev. Cell Dev. Biol., 2012, 28, 523.CrossRefGoogle Scholar
  10. 10.
    D. V. Maltseva, S. A. Rodin, Mol. Biol. (Moscow), 2018, 52, 350.CrossRefGoogle Scholar
  11. 11.
    G. Giannelli, A. Azzariti, E. Fransvea, L. Porcelli, S. Antonaci, A. Paradiso, Br. J. Cancer, 2004, 91, 1964.CrossRefGoogle Scholar
  12. 12.
    O. Govaere, J. Wouters, M. Petz, Y. P. Vandewynckel, K. Van Den Eynde, A. Van Den Broeck, S. Verhulst, L. Dollé, L. Gremeaux, A. Ceulemans, F. Nevens, L. A. Van Grunsven, B. Topal, H. Vankelecom, G. Giannelli, H. Van Vlierberghe, W. Mikulits, M. Komuta, T. Roskams, J. Hepatol., 2016, 64, 609.CrossRefGoogle Scholar
  13. 13.
    S. Rodin, L. Antonsson, C. Niaudet, O. E. Simonson, E. Salmela, E. M. Hansson, A. Domogatskaya, Z. Xiao, P. Damdimopoulou, M. Sheikhi, J. Inzunza, A.-S. Nilsson, D. Baker, R. Kuiper, Y. Sun, E. Blennow, M. Nordenskjöld, K.-H. Grinnemo, J. Kere, C. Betsholtz, O. Hovatta, K. Tryggvason, Nat. Commun., 2014, 5, 1.CrossRefGoogle Scholar
  14. 14.
    S. Vanharanta, J. Massagué, Cancer Cell, 2013, 24, 410.CrossRefGoogle Scholar
  15. 15.
    M. Doi, J. Thyboll, J. Kortesmaa, K. Jansson, A. Iivanainen, M. Parvardeh, R. Timpl, U. Hedin, J. Swedenborg, K. Tryggvason, J. Biol. Chem., 2002, 277, 12741.CrossRefGoogle Scholar
  16. 16.
    D. B. Longley, D. P. Harkin, P. G. Johnston, Nat. Rev. Cancer, 2003, 3, 330.CrossRefGoogle Scholar
  17. 17.
    D. Chen, L. Wei, J. Yu, L. Zhang, Clin. Cancer Res., 2014, 20, 3472.CrossRefGoogle Scholar
  18. 18.
    S. M. Wilhelm, L. Adnane, P. Newell, A. Villanueva, J. M. Llovet, M. Lynch, Mol. Cancer Ther., 2008, 7, 3129.CrossRefGoogle Scholar
  19. 19.
    J. Barretina, G. Caponigro, N. Stransky, K. Venkatesan, A. Margolin, S. Kim, C. J. Wilson, J. Lehár, G. V. Kryukov, D. Sonkin, A. Reddy, M. Liu, L. Murray, M. F. Berger, J. E. Monahan, P. Morais, J. Meltzer, A. Korejwa, J. Jané-Valbuena, Nature, 2012, 483, 603.CrossRefGoogle Scholar
  20. 20.
    N. A. Khaustova, D. V. Maltseva, L. Oliveira-Ferrer, C. Stürken, K. Milde-Langosch, J. A. Makarova, S. Rodin, U. Schumacher, A. G. Tonevitsky, Biochimie, 2017, 142, 197.CrossRefGoogle Scholar
  21. 21.
    V. Ramovs, L. te Molder, A. Sonnenberg, Matrix Biol., 2017, 57–58, 213.Google Scholar
  22. 22.
    T. R. Samatov, M. U. Shkurnikov, S. A. Tonevitskaya, A. G. Tonevitsky, Prog. Histochem. Cytochem., 2015, 49, 21.CrossRefGoogle Scholar
  23. 23.
    T. R. Samatov, A. G. Tonevitsky, U. Schumacher, Mol. Cancer, 2013, 12, 107.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • D. V. Maltseva
    • 1
    • 2
    Email author
  • G. S. Zakharova
    • 1
  • S. A. Rodin
    • 1
    • 3
  • A. G. Tonevitsky
    • 1
  1. 1.Scientific Research Center BioclinicumMoscowRussian Federation
  2. 2.National Medical Research Radiology CenterMinistry of Health of the Russian FederationObninskRussian Federation
  3. 3.Department of Medical Biochemistry and BiophysicsKarolinska InstitutetStockholmSweden

Personalised recommendations